X-group (possible homology)

322 HPr-like

Open in classification tree →

Ligands and drugs

223

Member domains

with ligand contacts (≤ 4 Å)

21.5% of members

with DrugDomain annotations

22.9% of members

with a DrugBank compound

17.5% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

Proteins with classified ligands

Superclasses bound (of 23)

—

Superclasses per 20 proteins

fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

Superclass	Proteins	Expected	Ratio	Significance
Homogeneous non-metal compounds	2	1.3	1.57×	not tested
Lipids and lipid-like molecules	1	0.7	1.52×	not tested
Homogeneous metal compounds	4	2.9	1.38×	not tested
Organoheterocyclic compounds	1	0.9	1.10×	not tested

enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBank	PDB ligand	Name	Domains
DB02210	HEZ	Hexane-1,6-Diol	4
DB00627	NIO	Niacin	1

Most frequently bound compounds

PDB ligand	Name	Domains in contact
HEZ	HEXANE-1,6-DIOL	6
CAmetal	CALCIUM ION	3
CDmetal	CADMIUM ION	2
NIO	NICOTINIC ACID	2
PO3	PHOSPHITE ION	2
ZNmetal	ZINC ION	2
FE2metal	FE (II) ION	1
IOD	IODIDE ION	1
NImetal	NICKEL (II) ION	1